Prerna launches CANTEL™: A MicroRNA-based blood test for breast cancer screening

PrecisionRNA Biotech from Hyderabad has launched Cantel, a new microRNA blood test for breast cancer screening. This test offers a simple and accurate alternative to traditional methods. It aims to improve early detection rates in India. Cantel is designed for women aged 30 and above. The company is seeking investors for nationwide expansion.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FuEgW63
via IFTTT